| Brooke Allen, OTR/L | |
|
16838 E Palisades Blvd, Building B Suite 121, Fountain Hills, AZ 85268 | |
| (480) 837-2595 | |
| Not Available |
| Full Name | Brooke Allen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Hand |
| Location | 16838 E Palisades Blvd, Fountain Hills, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225470826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XH1200X | Occupational Therapist - Hand | OT60862592 (Washington) | Primary |
| Provider Name | Spooner Physical Therapy, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982825089 PECOS PAC ID: 9436063567 Enrollment ID: O20031113000588 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Physical Therapy & Hand Rehab, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184730095 PECOS PAC ID: 3476440447 Enrollment ID: O20040303000811 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Ahwatukee, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205057320 PECOS PAC ID: 2769379759 Enrollment ID: O20040303000925 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Phoenix Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1104048248 PECOS PAC ID: 5496739617 Enrollment ID: O20040615001765 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Desert Ridge, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124240270 PECOS PAC ID: 1759332893 Enrollment ID: O20050205000026 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Estrella Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043432115 PECOS PAC ID: 6002822467 Enrollment ID: O20060223000039 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Biltmore, P.c.. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1568885358 PECOS PAC ID: 7416173620 Enrollment ID: O20140724001233 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Peoria Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1609299494 PECOS PAC ID: 2365668480 Enrollment ID: O20140728000068 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Provider Name | Spooner Northwest Hand Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1891118626 PECOS PAC ID: 5092931873 Enrollment ID: O20140731001253 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Allen, OTR/L 700 Ne 87th Ave, Vancouver, WA 98664-4896 Ph: (360) 397-3352 | Brooke Allen, OTR/L 16838 E Palisades Blvd, Building B Suite 121, Fountain Hills, AZ 85268 Ph: (480) 837-2595 |
News Archive
A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of matter" patents provide underlying intellectual property protection for surgical adhesives, films, and coatings. Nerites' scientists create synthetic mimetics of the protein components used by marine mussels to stick to rocks under water.
All age groups of depressed patients who received selective serotonin reuptake inhibitors - the most commonly prescribed antidepressant medication - showed a significantly lower risk of suicide attempt when compared to those who did not receive antidepressant treatment.
› Verified 6 days ago
Brian Paulsen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15215 E Palisades Blvd, Fountain Hills, AZ 85268 Phone: 480-221-2573 | |
Mr. William Charles High, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16000 E Palisades Blvd, Fountain Hills, AZ 85268 Phone: 480-664-5018 | |
Lori Borowitz, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15410 E Acacia Way, Fountain Hills, AZ 85268 Phone: 513-260-5751 | |
Sarah Starkey, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd, 225, Fountain Hills, AZ 85268 Phone: 480-837-4565 | |
Katlyn Tavarres, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd Ste 600, Fountain Hills, AZ 85268 Phone: 480-837-4565 | |
Mrs. Allyson Zimmer, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd Ste 600, Fountain Hills, AZ 85268 Phone: 480-837-4565 | |
Dr. Rachael Magdalene Voysey, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17100 E Shea Blvd, Fountain Hills, AZ 85268 Phone: 732-272-4604 |